A new study in Nature Nanotechnology introduces a radically different approach to colorectal cancer immunotherapy: peptide-based nanorobots that simultaneously block…
Browsing: Clinical Updates
New biomechanical evidence suggests that increased stiffness of the colon—driven by chronic inflammation and tissue scarring—may play a central role…
Earlier and more widespread adoption of advanced therapies—including biologics and small molecules—has not meaningfully altered long-term outcomes in Crohn’s disease…
An AI-enabled digital collaborative care model significantly improved symptoms in patients with irritable bowel syndrome (IBS), demonstrating how clinician-guided AI…
The American Gastroenterological Association’s 2025 clinical guidance reflects a clear shift toward risk-based, personalized, and technology-enabled GI care—aimed at helping…
A large international microbiome study has identified a distinct and consistent bacterial shift at the very onset of inflammatory bowel…
The FDA’s approval of oral semaglutide (Wegovy) marks a watershed moment for obesity and cardiometabolic care, introducing the first once-daily…
This year featured a wealth of clinically important publications in gastroenterology, making it difficult to choose only 10 to highlight.…
A large French cohort study found that delays of up to 24 months after a positive fecal immunochemical test (FIT)…
Researchers at the University of Pennsylvania found that cognitive behavioral therapy (CBT), delivered via telehealth, significantly reduced disability in patients…